Attgeno, home of Supernitro, is a Swedish clinical stage pharmaceutical company founded by a research group at the Karolinska Institute, Stockholm, to develop and bring to market new nitric oxide (NO)-donating technology and products. Our first drug candidate, Supernitro, is based on a novel principle developed by Attgeno and is intended to reverse life-threatening high blood pressure in the lungs (acute pulmonary hypertension, aPH).
| Website | https://attgeno.com/ |
| Revenue | $1 million |
| Employees | 8 (2 on RocketReach) |
| Founded | 2006 |
| Address | 2a Fogdevreten, Solna, Stockholm 171 65, SE |
| Phone | +46 70 645 78 27 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Drug Discovery, Manufacturing, Biotechnology |
| Keywords | Pharmaceutical, Drug Development, Drug Discovery, Clinical Stage, New Drug Applications, Clinical Trials, Biotechnology, Therapeutics, Pharma, Life Sciences, Innovation, Healthcare, Treatment, Research, Technology, Products, Medical |
| Competitors | Thermo Fisher Scientific, Illumina, QIAGEN, Roche, Agilent Technologies, Bio-Rad Laboratories, Merck Group, PerkinElmer, Inc., SAB Biotherapeutics , Inc., Novartis +44 more (view full list) |
| SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Attgeno employee's phone or email?
Attgeno Questions
The Attgeno annual revenue was $1 million in 2026.
2 people are employed at Attgeno.
Attgeno is based in Solna, Stockholm.
The NAICS codes for Attgeno are [325, 3254, 32541, 32].
The SIC codes for Attgeno are [2834, 28, 283].
Top Attgeno Employees
-
Per Agvald
VD at Attgeno
Stockholm, SE3 -
Christos Tsakalos
Executive Assistant at Attgeno
Stockholm, SE1
Related Companies
